This review has aimed to highlight the successful treatment of steroid-refractory and steroid-dependent, acute and chronic GvHD with ECP. This novel treatment appears to offer selective ...

Insight Partners is exploring a sale of PDI Technologies, which provides software to convenience stores, according to people with knowledge of the matter. The firm has tapped an adviser to solicit ...

So far, this type of analysis has been particularly useful in clinical oncology, but the technology is being actively and successfully explored for diseases such as diabetes, endocrine tumors and ...

With over 35 years of IT expertise and partnerships with more than 8,000 technology providers, Insight Enterprises (NASDAQ:NSIT) provides end-to-end digital transformation solutions that help ...

In today’s data-driven era, successful CEOs are not just relying on instinct; they are leveraging technology to make smarter, faster, and more accurate decisions. Whether it’s using AI for ...

Fortune 500 solutions integrator Insight Enterprises is taking over British consultancy firm, New World Tech (NWT), in a move aimed at enhancing its expertise in driving digital transformation for ...

On the deal, Richard Wells, managing director at Insight Partners, said in a statement, “CentralReach has been a driving force in tech-enabled autism and IDD care, and it has been a privilege to ...

Cite this: Technology Insight: ECP for the treatment of GvHD-Can We Offer Selective Immune Control Without Generalized Immunosuppression? - Medscape - Jun 01, 2006. SR Marshall is a ...